N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy?
about
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunitiesN-acetylcysteine -- passe-partout or much ado about nothing?Superoxide regulation of endothelin-converting enzymeCholesterol lowering and coronary artery disease: mechanisms of risk reduction.Review: Clinical aspects of vascular remodeling.Current, new and future treatments in dyslipidaemia and atherosclerosis.Antioxidants and coronary artery disease.Lipophilic calcium antagonists in antiatherosclerotic therapy.Basic mechanisms of stroke prevention with lipid-lowering therapy.Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.Matrix metalloproteinases and coronary artery diseases.Mechanisms of oxidative stress and vascular dysfunction.ERK/GSK3β/Snail signaling mediates radiation-induced alveolar epithelial-to-mesenchymal transition.Biomechanical regulation of human monocyte/macrophage molecular functionEndothelial mechanotransduction, nitric oxide and vascular inflammation.PPAR Agonists and Cardiovascular Disease in Diabetes.Cyclic strain-mediated matrix metalloproteinase regulation within the vascular endothelium: a force to be reckoned with.Therapeutic potential of the epidermal growth factor receptor transactivation in hypertension: a convergent signaling pathway of vascular tone, oxidative stress, and hypertrophic growth downstream of vasoactive G-protein-coupled receptors?NADPH oxidase 2 regulates bone marrow microenvironment following hindlimb ischemia: role in reparative mobilization of progenitor cells.Role of oxidative stress and nitric oxide in atherothrombosisOxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine induces vascular endothelial superoxide production: implication of NADPH oxidase.N-acetyl-cysteine attenuates remifentanil-induced postoperative hyperalgesia via inhibiting matrix metalloproteinase-9 in dorsal root ganglia.Basal and oxidative stress-induced expression of metallothionein is decreased in ascending aortic aneurysms of bicuspid aortic valve patientsEffect of Smoking on Metalloproteinases (MMPs) Activity in Patients with Acute Myocardial Infarction (AMI).Modulation of Systemic Metabolism by MMP-2: From MMP-2 Deficiency in Mice to MMP-2 Deficiency in Patients.Astaxanthin suppresses scavenger receptor expression and matrix metalloproteinase activity in macrophages.Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophages.In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.Changes in Activities of MMP in Alcohol and Thermally Oxidized Sunflower Oil-Induced Liver Damage: NAC Antioxidant Therapy.Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction.Matrix metalloproteinase-9 is elevated in serum of alcohol abusers.Inhibitory effects of N-acetylcysteine on scavenger receptor class A expression in human macrophages.Growth factor stimulation of matrix metalloproteinase expression and myoblast migration and invasion in vitro.Dietary iron restriction increases plaque stability in apolipoprotein-e-deficient mice.Serum matrix metalloproteinase-9 is elevated in men with a history of myocardial infarction.Mediterranean diet and cardioprotection: wild artichoke inhibits metalloproteinase 9.Inhibitory effect of Ginkgo biloba extract on hyperhomocysteinemia-induced intimal thickening in rabbit abdominal aorta after balloon injury.Red Grape Skin Polyphenols Blunt Matrix Metalloproteinase-2 and -9 Activity and Expression in Cell Models of Vascular Inflammation: Protective Role in Degenerative and Inflammatory Diseases.Increased myocardial matrix metalloproteinases in hypoxic newborn pigs during resuscitation: effects of oxygen and carbon dioxide
P2860
Q24568289-8B2C314A-364C-46DE-AD14-458FC199AC9DQ24678741-AB016BF9-6E2B-4A0F-A2CB-D1E4B7932F2DQ28145487-CAFDED58-1F9C-4B64-8708-A0324CE6088DQ33538129-18B8C242-76BC-4649-A537-E53868A0E430Q33691209-8C3E664C-C7E2-439B-9942-F0D464D2BF00Q33993678-715096CE-200B-4919-93D4-5EBD1F9D30F0Q34107270-4E3E6021-948D-4694-B265-958FB8FC69D0Q34107334-97C411AA-7A95-4C63-9F90-C572EE97240AQ34107366-4C34BE99-8E2E-40D2-ACC3-A840F387F380Q35050827-910E488F-30DD-4271-8A21-D6D474EA9867Q35081023-3F5C2BE9-690C-4CF3-8B79-8708F1515DB5Q35125992-AA91B509-84C7-470B-AE2D-F4C36C68F8ACQ35783218-65354076-F699-40CE-B48C-FADB728CF569Q35810235-0F3EEE34-F288-4463-A3EF-B0716C39ACCAQ36440491-4FF412B5-2FCC-429B-B67D-0489F19987BCQ36444975-B93D8A33-7159-4450-9D8C-9C9E3066701FQ36584877-B2CEF53E-1834-4D80-9808-32783773986CQ36814764-FD85DA17-4006-452B-B53E-5D6ED976ACC7Q36987722-BEA9CC6B-ADBD-462D-BAD6-56C872216265Q37045445-71469467-7AD3-4402-94FB-17181E14A7F5Q37166505-58B4C435-B67E-4F3F-9B4A-F0F927B4B746Q37725555-A6D1EAE3-2E05-4D10-9326-4CB64C2C2D1DQ38354648-9336DE05-83BC-4120-BAF8-41E32C7302E7Q38587974-9D4F48B0-6D22-4C6D-B59E-9B82DB323DA3Q38991475-D1D65609-E64B-43B2-A85E-8BF0CBC22D55Q39794511-81620EF9-9605-48EC-91C0-C89931B2CCEDQ40220343-BE15A955-5B9E-414F-96FB-94D03E507B7CQ42774386-64BBD81F-ED88-4642-8A06-0B7506E4144DQ43215714-C85402CE-F683-41BB-A55B-8E4EF96AC609Q43800025-1A78895B-206C-447A-A917-E9FE5571AD76Q43959103-ED4B1C28-B458-4BBE-B791-667632034BC2Q43975480-F6CEE07C-7148-4640-B70B-95FF00689375Q44238462-FAB99CCA-411F-433E-862B-4E1DFF6B3E2AQ44556133-B5476964-921B-4BCB-B563-CED9E8E3FF0FQ44955636-54225BF9-9623-445B-AB82-B5C522EF1BA3Q46470012-01948981-B1D3-4205-AFAB-1216530DA27CQ46827044-C9FF3EE8-EF32-42E2-9F85-F6C9C8455EF5Q50229564-DD99FD0D-DAF1-4F31-8D56-AFABD35E6761Q58143867-65CD89F3-F22D-464E-AA24-2B5EEC1E46F4
P2860
N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy?
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
N-acetyl-cysteine decreases th ...... arget for antioxidant therapy?
@en
N-acetyl-cysteine decreases th ...... arget for antioxidant therapy?
@nl
type
label
N-acetyl-cysteine decreases th ...... arget for antioxidant therapy?
@en
N-acetyl-cysteine decreases th ...... arget for antioxidant therapy?
@nl
prefLabel
N-acetyl-cysteine decreases th ...... arget for antioxidant therapy?
@en
N-acetyl-cysteine decreases th ...... arget for antioxidant therapy?
@nl
P2093
P1433
P1476
N-acetyl-cysteine decreases th ...... arget for antioxidant therapy?
@en
P2093
P304
P356
10.1161/01.CIR.97.24.2445
P407
P577
1998-06-01T00:00:00Z